Fact-checked by Grok 2 weeks ago

Lactose intolerance

Lactose intolerance is a clinical characterized by the body's inability to fully digest , a sugar found in and dairy products, due to insufficient production of the enzyme in the . This leads to lactose malabsorption, where undigested ferments in the colon, causing gastrointestinal symptoms such as , , , , and , typically occurring within 30 minutes to two hours after consuming lactose-containing foods or beverages. Unlike a , which involves an to proteins and can cause systemic reactions like or , lactose intolerance is a non-allergic digestive disorder that is generally harmless but can impact if unmanaged. The condition affects a significant portion of the global population, with approximately 68% of people worldwide experiencing lactose malabsorption, though not all develop noticeable symptoms. In the United States, about 36% of individuals have lactose malabsorption, with prevalence varying by ethnicity: it is more common among (up to 75-95%), Hispanics/Latinos (50-80%), (90-100%), and (80-100%), while less frequent in people of descent (5-15%). Risk factors include increasing age, as lactase levels naturally decline after childhood in most populations; , particularly in lactase nonpersistence, the most common form where enzyme production decreases after ; premature birth; and conditions or treatments that damage the , such as , , infections, or . Lactose intolerance manifests in several types, each with distinct etiologies. Primary lactose intolerance, or lactase nonpersistence, arises from a genetic decline in production and typically emerges in or adulthood. Congenital lactase deficiency, a rare autosomal recessive disorder, results in little to no from birth, causing severe symptoms in infants fed or formula. Secondary lactose intolerance develops temporarily due to injury or illness affecting the , such as , disease, or , and may resolve with of the underlying cause. Premature infants may also experience a developmental form that improves as the gut matures. Symptoms' severity depends on the amount of consumed and individual tolerance levels, with some people able to digest small amounts without issue. Management of lactose intolerance focuses on symptom relief rather than cure, primarily through dietary modifications to reduce or eliminate intake while ensuring nutritional adequacy. Many individuals can tolerate lactose-free products, hard cheeses, , or plant-based alternatives, and gradually increasing exposure may build tolerance in some cases. Over-the-counter enzyme supplements, taken before meals, help digest for those who wish to consume . Complications are rare but may include nutritional deficiencies, such as low calcium or , if is strictly avoided without supplementation; consulting a healthcare provider is recommended for via hydrogen breath tests or elimination diets and to address any secondary causes.

Fundamentals

Definition and Terminology

Lactose intolerance is a digestive characterized by the small intestine's insufficient of the , which is necessary to hydrolyze —a disaccharide sugar found in and products—into its absorbable monosaccharides, glucose and . When activity is inadequate, undigested passes into the colon, where it is fermented by gut , producing gases and drawing water into the bowel via . This condition primarily affects the ability to tolerate lactose-containing foods, leading to variable symptom severity based on the degree of deficiency and lactose load. Lactose intolerance must be distinguished from , as the former arises from an enzymatic deficiency in lactose digestion, whereas the latter involves an immune-mediated response to milk proteins such as or , potentially causing , , or other systemic reactions. Unlike the non-immunologic nature of lactose intolerance, engages the and requires avoidance of milk proteins rather than just . Key terminology includes hypolactasia, which denotes a partial reduction in lactase activity, often occurring post-weaning in most populations; alactasia, referring to a complete absence of , typically seen in rare congenital cases; and lactose malabsorption, a broader physiological process describing the incomplete absorption of lactose in the , which may or may not result in symptomatic intolerance. These terms highlight the spectrum from enzyme deficiency to clinical manifestation, with lactose malabsorption encompassing the underlying maldigestion that precedes intolerance symptoms. Lactose intolerance, often manifesting as adult-type hypolactasia, represents the global norm, affecting approximately 65-70% of adults worldwide, with higher prevalence in Asian, , and Native American populations and lower rates in those of Northern European descent.

Physiology of Lactose Digestion

is a composed of one of D-glucose and one molecule of D-galactose, linked by a β-1,4-glycosidic bond. This carbohydrate is the primary sugar in mammalian milk and requires enzymatic breakdown for efficient digestion. In the human digestive system, lactose digestion occurs primarily in the small intestine, where the enzyme lactase (also known as lactase-phlorizin hydrolase) is embedded in the brush border membrane of enterocytes. Lactase catalyzes the hydrolysis of lactose into its constituent monosaccharides through the reaction: \text{lactose} + \text{H}_2\text{O} \rightarrow \text{glucose} + \text{galactose} This enzymatic action releases the absorbable glucose and galactose units directly at the site of absorption. Following , the monosaccharides glucose and are absorbed across the apical membrane of enterocytes via the sodium-dependent cotransporter SGLT1, which uses the sodium gradient to actively transport them into the . From the , these monosaccharides exit the basolateral membrane into the bloodstream primarily through the facilitative GLUT2, enabling their delivery to the liver and peripheral tissues for energy metabolism. In normal digestion, this efficient breakdown and of lactose prevent undigested disaccharides from reaching the colon, thereby avoiding osmotic imbalances that could draw water into the intestinal . Lactase expression is typically high during infancy to support consumption but declines post-weaning in most mammals, including humans, as an to shifting diets; however, —continued enzyme production into adulthood—has evolved as a genetic in certain populations reliant on for .

Clinical Presentation

Signs and Symptoms

Lactose intolerance manifests primarily through gastrointestinal symptoms that arise after consuming -containing foods or beverages. These symptoms typically begin 30 minutes to 2 hours following ingestion, as undigested reaches the colon. Common manifestations include abdominal , cramps, , and , the latter resulting from the osmotic draw of water into the intestines due to unabsorbed . is also frequent, while and occur less commonly in some individuals. The underlying of by colonic contributes to gas production and . The severity of these symptoms varies based on several factors, including the amount of lactose consumed, the individual's residual lactase enzyme activity, and gut transit time. Higher lactose doses generally exacerbate symptoms, whereas lower amounts may cause minimal discomfort. Non-gastrointestinal effects, such as or , are rare and often secondary to from . Symptom thresholds differ among affected individuals, with many tolerating up to 12 grams of daily—roughly equivalent to one glass of —without significant issues, particularly when consumed with other foods. This variability underscores the condition's individualized nature, where some people experience no symptoms from small portions.

Differential Diagnosis

Lactose intolerance often presents with gastrointestinal symptoms such as , , and that overlap significantly with other common digestive disorders, necessitating careful clinical differentiation to guide appropriate management. Key conditions in the differential diagnosis include (IBS), celiac disease, (IBD), milk protein allergy, (SIBO), and , as these can mimic or coexist with lactose-related complaints. Distinguishing lactose intolerance typically relies on its specific association with consumption and resolution upon lactose avoidance, unlike the more persistent or trigger-diverse patterns in other disorders. Irritable bowel syndrome (IBS) is a frequent mimic due to shared symptoms of abdominal discomfort and altered bowel habits, but IBS exhibits a chronic, relapsing pattern without a clear dietary trigger like . Notably, 59% of IBS patients may have concurrent lactose intolerance, highlighting substantial overlap with functional gastrointestinal disorders. Celiac disease can cause secondary lactose intolerance through small intestinal damage, leading to ; however, it involves sensitivity, systemic effects like , and villous atrophy on , which are absent in primary lactose intolerance. Inflammatory bowel disease (IBD), such as , presents with similar and pain but is characterized by inflammatory markers, , bloody stools, and endoscopic evidence of mucosal ulceration, contrasting with the non-inflammatory, dairy-specific nature of lactose intolerance. Milk protein allergy differs fundamentally as an immune-mediated response to cow's milk proteins (e.g., casein or whey), often causing immediate symptoms like hives, vomiting, or anaphylaxis in addition to gastrointestinal issues, whereas lactose intolerance is a non-allergic digestive enzyme deficiency limited to osmotic effects from undigested lactose. Small intestinal bacterial overgrowth (SIBO) can exacerbate or mimic lactose intolerance by fermenting carbohydrates, producing excess hydrogen and similar bloating; however, SIBO is identified through breath testing showing early hydrogen peaks and may require antibiotic treatment, unlike the lactase-specific deficit in lactose intolerance. Fructose malabsorption shares fermentative symptoms like gas and diarrhea but is triggered by fruits, honey, or high-fructose corn syrup rather than dairy, and it frequently coexists with lactose malabsorption, with an overlap of about 33% in patients with functional gastrointestinal disorders. Lactose intolerance may also play a role in broader conditions, such as exacerbating symptoms in through increased gastric distension or post-infectious gut sensitivity following viral . Clinicians should suspect lactose intolerance when patients report a clear history of dairy-triggered symptoms without red flags like unintentional , , or nocturnal , which point toward IBD or .

Etiology

Types of Lactose Intolerance

Lactose intolerance is classified into four main types based on its onset and underlying mechanism: primary, secondary, developmental, and congenital. These distinctions help in understanding the and guiding appropriate management, though the normal of lactose digestion involves activity in the . Primary hypolactasia, also known as adult-onset or late-onset lactase deficiency, is the most prevalent form worldwide. It results from a genetically programmed gradual decline in production after , typically becoming symptomatic in or early adulthood. This type, often referred to as lactase non-persistence, represents the ancestral where levels decrease as dietary reliance on diminishes post-infancy. Secondary lactose intolerance arises from acquired damage to the intestinal mucosa, leading to temporary or reversible reduction in lactase activity. Common causes include gastrointestinal infections (such as or ), inflammatory conditions like celiac disease or , , or other injuries to the . Unlike primary forms, this type often resolves with of the underlying condition, restoring normal lactase function. Secondary forms are less common overall, particularly in children from developing regions prone to infections. Congenital alactasia is a rare autosomal recessive disorder characterized by complete or near-total absence of enzyme from birth due to mutations affecting its production. Affected infants present with severe watery , , and shortly after consuming , requiring lifelong dietary avoidance of . Only around 40 cases have been documented globally, with most reported in populations. Developmental lactose intolerance occurs transiently in premature infants born between 28 and 37 weeks , stemming from an immature intestinal lining that has not yet fully developed sufficient production. Symptoms typically manifest as feeding intolerance but resolve spontaneously as the gut matures over weeks to months, aligning with post-term . In terms of prevalence, primary hypolactasia dominates globally, affecting approximately 65% to 70% of the world's , with higher rates in non-European populations such as those of Asian, , and South American descent (up to 90-100% in some groups), while lower in Northern Europeans (around 5-15%). Congenital and developmental types remain exceedingly rare, comprising a small fraction of total lactose intolerance instances.

Genetic and Molecular Basis

Lactose intolerance, or more precisely lactase non-persistence, primarily arises from the genetic regulation of the enzyme encoded by the LCT gene on 2q21.3. In most humans, LCT expression declines sharply after due to regulatory elements in the nearby MCM6 gene, which acts as an enhancer for LCT transcription. The most studied variant associated with in populations of European descent is the -13910C>T (rs4988235) located approximately 13.9 kb upstream of the LCT coding region in an MCM6 ; the T enhances LCT expression into adulthood, enabling continued lactose digestion. Lactase non-persistence follows an autosomal recessive pattern, requiring biallelic absence of persistence-conferring variants for the to manifest post-weaning. These persistence mutations emerged independently in different populations between approximately 2,000 and 20,000 years ago, aligning with the rise of dairy during the period. For instance, the -13910T likely originated in around 7,500 years ago under strong selective pressure from consumption as a nutrient source in famine-prone environments. At the molecular level, lactase non-persistence results from epigenetic silencing of LCT, involving at promoter and enhancer regions as well as histone deacetylation, which represses transcription after infancy. In contrast, persistence alleles such as -13910T modify the enhancer's binding affinity for transcription factors like Oct-1 and HNF1α, thereby counteracting this age-dependent downregulation and sustaining LCT mRNA levels in intestinal enterocytes. Recent investigations have highlighted haplotype-specific epigenetic landscapes, where non-persistence haplotypes accumulate repressive marks more readily than persistence ones. Post-2017 genome-wide association studies (GWAS) have expanded understanding beyond the European-centric -13910T variant, identifying additional persistence alleles in diverse ancestries. In African populations, such as the Fulani nomads, variants like -14010C>G and -13915T>G show strong associations with , confirmed through targeted GWAS linking them to LCT expression. Similarly, studies in Asian and Northeast African groups, including Sudanese ethnicities, have uncovered rare alleles like -22018A>G, contributing to a polygenic architecture of persistence. These findings enable polygenic risk scores that integrate multiple variants for improved phenotypic prediction across global populations. Evolutionarily, lactase persistence alleles underwent rapid positive selection in pastoralist societies, where dairy provided a caloric advantage, particularly during arid conditions or post-agricultural transitions. This selection is evident in frequency clines correlating with historical dairying practices, resulting in approximately 35% of the global adult population exhibiting today, predominantly in regions with longstanding milk use.

Microbiome Influence

In individuals with lactose intolerance, undigested reaches the colon, where it is fermented by , primarily saccharolytic such as and species. These break down into monosaccharides, producing gases including (H₂), (CO₂), and (CH₄), as well as (SCFAs) like acetic, propionic, and butyric acids. This fermentation process contributes to osmotic effects and gas accumulation, exacerbating symptoms such as , , and , with faecal samples from lactose-intolerant individuals showing faster and higher SCFA production upon incubation compared to tolerant controls. Microbiome composition varies among lactose-intolerant individuals, with —characterized by reduced α-diversity (e.g., lower richness and evenness metrics like Chao1 and )—often linked to more severe symptom fermentation. For instance, increased abundance of in genetically lactose-intolerant adults correlates positively with gut complaint severity (R=0.33, p=0.003), potentially due to enhanced gas and SCFA production, while shifts toward Proteobacteria or may amplify and proinflammatory responses like elevated IL-6 and IL-1β. Lower microbial diversity is associated with worsened osmotic and pain thresholds in experimental models of lactose intolerance. Emerging research from the 2020s highlights the microbiome's potential for modulation to alleviate symptoms. supplementation with β-galactosidase-producing strains, such as , has been shown to enhance and reduce and in clinical trials, with one 2021 study demonstrating improved results and symptom scores after acute administration. Similarly, fecal transplantation (FMT) has shown promise in secondary cases, as evidenced by a 2025 where FMT restored to and other foods in a with severe multi-food intolerance, including , by increasing levels and normalizing stool consistency. These interventions underscore the microbiome's role in boosting lactose-metabolizing capacity without addressing the primary enzymatic deficiency. Dietary patterns and antibiotics significantly influence microbiome dynamics, thereby modulating the severity of secondary lactose intolerance. High-lactose or fiber-rich diets can promote beneficial shifts, increasing Bifidobacterium and SCFA production to mitigate symptoms, while antibiotic exposure disrupts lactose-fermenting taxa, reducing diversity and exacerbating intolerance through impaired fermentation balance. Overall, while the gut microbiome does not cause primary lactose intolerance—which stems from lactase deficiency—it acts as a key modulator, amplifying osmotic and gaseous effects based on its composition and environmental interactions.

Diagnostic Approaches

Non-Invasive Tests

Non-invasive tests for lactose intolerance provide patient-friendly methods to assess malabsorption or deficiency without requiring tissue sampling or invasive procedures. These approaches are particularly valuable for initial screening and confirmation in clinical settings, focusing on physiological responses to ingestion or direct genetic analysis. The serves as the gold standard for diagnosing malabsorption in adults. In this procedure, the patient ingests 25-50 grams of dissolved in after , and breath samples are collected at baseline and at intervals (typically every 15-30 minutes for 2-3 hours) to measure exhaled levels using a breath analyzer. An increase in exceeding 20 parts per million (ppm) above indicates colonic bacterial of unabsorbed , confirming malabsorption. This test is highly sensitive and specific, with advantages including its office-based nature, lack of , and ability to correlate with symptoms during the procedure. However, limitations include potential false negatives in individuals who produce instead of (), affecting up to 15% of cases, and the need for dietary preparation to avoid interfering substances. The tolerance test evaluates small intestinal absorption through . Following overnight , the patient consumes 50 grams of , and blood samples are drawn at baseline, 30 minutes, 60 minutes, and 120 minutes to measure glucose levels. A rise of less than 20 mg/dL above baseline signifies , as undigested fails to break down into glucose and for absorption. Although historically common, this test is now less favored due to frequent induction of gastrointestinal symptoms like and , which can mimic or exacerbate intolerance signs. Its advantages lie in direct assessment of absorption, but it requires and may be inconclusive in patients with or impaired glucose metabolism. For infants and young children, the stool acidity test offers a simple, non-invasive option to detect malabsorption. After a period of or -containing formula intake, a sample is analyzed for pH and reducing substances. A pH below 5.5, resulting from the of unabsorbed into and other by colonic , indicates intolerance. This test is particularly useful in pediatric populations where breath or blood tests may be challenging, providing quick results with minimal discomfort. Limitations include its indirect nature and potential for false positives in other diarrheal conditions, necessitating correlation with clinical symptoms. Stool sugar chromatography detects unmetabolized and other reducing sugars in fecal samples after lactose ingestion, providing evidence of specific to infants and young children where breath tests may be unreliable. The procedure involves collecting a stool sample, followed by chromatographic separation to identify profiles; presence of reducing sugars ≥0.5%, with chromatography confirming , suggests intolerance. It is useful in pediatric cases with or but lacks utility in adults due to variable gut transit and interference. Drawbacks include the need for specialized analysis and potential false positives from non-specific sources. Genetic testing targets primary lactose intolerance by identifying polymorphisms in the (LCT). A swab or small blood sample is used for () analysis to detect variants such as the C/T-13910 polymorphism upstream of the LCT . The CC is associated with adult-type hypolactasia ( non-), while TT indicates persistence; heterozygous CT may show intermediate activity. This method is highly specific for confirming in populations with primary intolerance, offering advantages like one-time testing without challenge and applicability across ages. It is especially useful in or when functional tests are inconclusive, though limitations include its inability to detect secondary causes and variable relevance in non-European ancestries where other polymorphisms predominate. Overall, these non-invasive tests facilitate accessible , with the preferred for its balance of accuracy and practicality in most adults, while and genetic options suit specific demographics.

Invasive Tests

Invasive tests for lactose intolerance involve direct assessment of activity or unmetabolized sugars through tissue sampling or fluid aspiration, typically reserved for cases where non-invasive methods are inconclusive or secondary causes like celiac disease are suspected. These approaches provide high specificity but are limited by procedural risks, cost, and the need for . The gold standard invasive test is the intestinal biopsy, obtained via upper gastrointestinal endoscopy from the duodenal or jejunal mucosa. Biopsy specimens are analyzed for lactase activity using enzymatic assays, with normal levels exceeding 15 units per gram of protein (U/g protein); values below 10-15 U/g protein indicate deficiency. A comprehensive disaccharidase panel, measuring lactase alongside sucrase and maltase activities, aids in differential diagnosis by identifying isolated lactase deficiency versus broader mucosal disorders. This method is particularly indicated for confirming secondary lactase deficiency in conditions such as celiac disease or inflammatory bowel disease, offering precise quantification of enzyme function. However, it is rarely performed as a first-line test due to its invasiveness, requirement for endoscopic expertise, potential complications like bleeding or perforation, and high cost.

Management Strategies

Dietary Interventions

Dietary interventions for lactose intolerance primarily involve reducing or modifying intake to alleviate symptoms while maintaining nutritional balance. The main strategy is to limit consumption of high- foods, as maldigestion leads to in the gut, causing discomfort. Individuals can often tolerate small amounts of , particularly when consumed with other foods, allowing for personalized adjustments rather than complete elimination. Common dairy products vary significantly in lactose content; for example, cow's contains approximately 12 grams of per cup (240 mL), while has about 6-7 grams per half-cup serving, and plain ranges from 11-17 grams per cup but is often better tolerated due to bacterial during production. Aged or hard cheeses, such as cheddar or Parmigiano Reggiano, contain very low levels, typically less than 1 gram per ounce or even under 0.01 grams per 100 grams, making them suitable options. Hidden in processed foods, like breads, cereals, and medications, requires careful label reading to identify ingredients such as , solids, or curds. To identify a personal threshold, a gradual reduction or introduction of is recommended, starting with small portions like one-quarter cup of with meals and increasing slowly over days or weeks. Many people can handle 9-12 grams of per meal—equivalent to about one cup of —especially when paired with solids or fats that slow , and up to 18-24 grams spread throughout the day without significant symptoms. Fermented products like or certain cheeses are generally better tolerated because the process reduces content and aids through live . Nutritional considerations are crucial, as dairy provides a major source of calcium (up to 72% of intake in some diets) and ; restricting it risks deficiencies, with studies showing intakes as low as 388-739 mg of calcium per day against a recommended 1,000 mg. Alternatives include fortified plant-based milks (e.g., soy or ), leafy greens like , set with , and fish with edible bones such as sardines. In high-prevalence regions like , where lactose intolerance affects around 90% of the population, traditional diets adapt culturally by minimizing fresh and emphasizing low-lactose fermented products (e.g., or ) or plant-based calcium sources, reducing reliance on unprocessed .

Pharmacological and Supplemental Treatments

Pharmacological treatments for lactose intolerance primarily involve enzyme replacement therapy using supplements, which provide exogenous beta-galactosidase to aid in . These supplements, such as those branded as Lactaid, are derived from microbial sources like yeasts or fungi and are taken orally with the first bite or sip of a dairy-containing meal to hydrolyze into and , thereby reducing gastrointestinal symptoms. Dosage recommendations for lactase supplements typically range from 3,000 to 9,000 Food Chemical Codex (FCC) units per meal, adjusted based on the estimated lactose content of the food consumed, with higher doses for larger amounts of . These products are widely available over-the-counter in tablet, capsule, or liquid drop forms, allowing users to tailor intake to individual needs without a prescription. For managing acute symptoms like , antidiarrheal agents such as can provide symptomatic relief by slowing intestinal motility, though they do not address the underlying maldigestion and are not intended for preventive use. is typically dosed at 2-4 mg after loose stools, up to a maximum of 16 mg per day for adults, and may be considered adjunctively during episodes triggered by inadvertent exposure. Long-term avoidance of dairy products to manage lactose intolerance can lead to inadequate calcium intake, necessitating supplementation to meet recommended daily requirements of 1,000-1,200 mg for most adults, often combined with to enhance absorption. Sources such as or citrate are commonly used, taken in divided doses with meals to improve tolerability and uptake. Clinical studies indicate that lactase supplements effectively reduce symptoms in many individuals, with one randomized trial showing a 55% decrease in hydrogen breath excretion—a marker of lactose maldigestion—and significant alleviation of bloating, abdominal pain, and diarrhea compared to placebo. Overall, these treatments enable approximately 75% of users to maintain a more normal diet including dairy, though efficacy may be limited in severe cases due to variable enzyme activity in the gut or high lactose loads.

Emerging Therapies

Recent research into and prebiotics has shown promise in alleviating lactose intolerance symptoms by enhancing activity and modulating the gut . Specific strains, such as combined with Lactobacillus rhamnosus, have demonstrated reductions in , , and in clinical trials, with meta-analyses indicating standardized mean differences in symptom scores ranging from -0.46 to -2.73, corresponding to moderate to substantial improvements depending on dosage and strain combination. Similarly, prebiotics like galacto-oligosaccharides (GOS) increase populations of lactose-fermenting bacteria such as and , leading to symptom alleviation in up to 71% of lactose-intolerant individuals after 36 days of supplementation in randomized controlled trials. These interventions, particularly from 2020s studies, report overall symptom reductions of 20-80% in bloating and pain, though outcomes vary by individual composition. Gene therapy concepts targeting the LCT , which encodes lactase-phlorizin , remain in early preclinical stages, primarily explored in animal models. (AAV) vectors delivering β-galactosidase transgenes have achieved persistent expression in gut , restoring digestion for at least six months post-administration. Engineered genetic circuits in strains, tested in mice, incorporate tri-stable switches to maintain β-galactosidase activity and stabilize colonic pH during challenges, preventing . As of 2025, human trials for CRISPR-based LCT editing are projected to initiate post-2025, focusing on safe, targeted corrections of lactase non-persistence variants. Microbiome modulation extends beyond to prebiotic strategies like GOS, which shift patterns by promoting beneficial short-chain production and reducing gas accumulation in the colon. For secondary lactose intolerance, often linked to gut from conditions like or infections, fecal microbiota transplantation (FMT) has shown therapeutic potential; in a 2025 case report, oral FMT capsules restored tolerance to lactose-containing foods by increasing Bifidobacterium abundance and enhancing β-galactosidase activity, resolving symptoms in a pediatric with multi-food intolerance. Early formulations incorporating symbiotic blends of and prebiotics are under evaluation in pilot trials, such as a 2025 study on GOS for modulation in lactose-intolerant adults. These efforts highlight potential for , where genetic profiling of LCT variants guides tailored interventions, integrating nutrigenomics to optimize selection and dosage for individual responses.

Epidemiology

Prevalence and Distribution

Lactose intolerance affects approximately 65% to 70% of the world's adult population, with a 2017 systematic review estimating global lactose malabsorption at 68% (95% CI 64-72%). This prevalence is notably higher among non-Caucasian populations, reflecting genetic adaptations to dairy consumption histories. Regional variations in prevalence are pronounced, driven by differences in lactase persistence alleles. In and , rates reach 90% to 100%, while in and parts of the , they range from 50% to 80%. In contrast, exhibits the lowest rates, at 5% to 15%. These patterns are corroborated by genetic surveys, such as a 2020 review mapping and frequencies worldwide, which highlight the scarcity of in non-European ancestries. Age-related patterns show near-universal lactase activity in infants to support milk digestion, with the decline in enzyme levels typically beginning between ages 3 and 5 years post-weaning. Symptoms of primary intolerance often emerge in late childhood, , or early adulthood, though onset can vary by ethnicity—earlier in Asian, , and populations. Epidemiological data from organizations like the and recent genetic studies in the 2020s confirm these global trends, emphasizing consistent distributions across diverse populations. Urban and rural prevalence remains similar within regions, though migration can alter dietary exposure and symptom recognition in affected individuals. Lactose intolerance is influenced by a combination of non-modifiable and modifiable risk factors. Non-genetic, modifiable risks primarily contribute to secondary lactose intolerance, which arises from damage to the or disruptions in gut function. Gastrointestinal infections, such as those caused by or , can temporarily reduce production by injuring the intestinal lining, leading to of . Similarly, use may induce transient lactose intolerance by altering the intestinal and damaging the where is produced, with symptoms often resolving as gut flora recovers. Radiation therapy to the abdomen, commonly used in , can also impair enzyme activity by causing mucosal damage to the . Demographic factors play a significant role in the predisposition to primary lactose intolerance, which is genetically determined but varies by population. Ethnicity is a key non-modifiable factor, with higher prevalence observed among individuals of Asian, African, Hispanic, and Native American descent due to lower rates of lactase persistence alleles. Age-related decline in lactase activity typically occurs post-weaning, with symptoms emerging in late childhood or adolescence as enzyme levels naturally decrease in most populations worldwide. Regarding sex, evidence from multiple studies shows no significant differences in prevalence or severity between males and females. Emerging trends reflect both increased awareness and environmental shifts affecting lactose intolerance. In Western countries, diagnoses have risen due to greater public and medical awareness, as evidenced by a sharp increase in online searches for lactose intolerance over the past decade, prompting more testing and self-reporting. In developing regions, dietary transitions toward higher dairy consumption—driven by , , and climate-induced changes in —may lead to more symptomatic cases among genetically predisposed populations, exacerbating undernutrition risks where lactose intolerance rates exceed 80%. Lactose intolerance is associated with certain comorbidities, often stemming from dairy avoidance and resultant nutrient deficiencies. In postmenopausal women, lactose intolerance has been associated with higher prevalence, potentially due to reduced calcium and intake; however, genetic studies indicate that non-persistence alleles may confer a lower overall risk of in the general population. Additionally, avoidance of products can contribute to by limiting calcium absorption, leading to lower density and increased risk, particularly when alternative calcium sources are inadequate. As of 2025, global rates of primary lactose intolerance remain stable, aligned with genetic patterns, with secondary cases influenced by ongoing trends in gastrointestinal disorders and gut challenges, such as post-infectious and microbiome disruptions from antibiotic use. This trend is expected to fuel growth in the treatment market, with secondary lactose intolerance segments showing expansion due to increasing incidences of underlying gut conditions like .

Historical Development

Early Observations

The earliest documented observations of symptoms resembling lactose intolerance date back to ancient Greece, where Hippocrates (c. 460–370 BCE) noted that while some individuals could consume cheese without issue, others experienced pain after eating a surfeit of it, highlighting individual variations in digestive capacity. In non-pastoral societies of Asia and Africa, traditional diets historically emphasized low or no fresh dairy consumption, favoring fermented alternatives like yogurt or cheese where available, or avoiding milk altogether due to recurrent digestive upset in adults. This pattern, observed in regions like East Asia and sub-Saharan Africa, reflects millennia of cultural adaptation to high rates of post-weaning lactase decline, with archaeological evidence showing limited reliance on unprocessed milk products until recent centuries. During the 17th and 18th centuries, physicians began noting adult-onset from in medical writings, describing how many individuals beyond infancy suffered and cramps after ingestion, often advising moderation or dilution to ease symptoms. These accounts, drawn from clinical observations in communities, highlighted a post-weaning decline in tolerance without identifying underlying mechanisms. In the , physicians in colonial settings observed variations in milk tolerance among different ethnic groups. Before the advent of genetic and enzymatic understandings in the , symptoms were often linked to general digestive issues; treatments focused on , dilution, or abstinence to prevent in the gut. This historical recognition profoundly shaped cultural practices, as non-pastoral societies worldwide avoided fresh milk for generations, incorporating dairy only in processed forms or substituting plant-based alternatives to mitigate digestive risks and sustain health.

Modern Research Advances

In the mid-20th century, significant progress was made in understanding the biochemical basis of lactose digestion through the isolation and characterization of the enzyme. During the and , researchers such as O. Koldovský advanced the field by studying the developmental regulation of intestinal disaccharidases, including , in animal models, demonstrating its localization and activity changes post-weaning. This work laid the groundwork for recognizing lactase deficiency as a developmental phenomenon rather than a pathological . Concurrently, the of non-invasive diagnostic tools emerged, with Michael D. Levitt's 1969 study on gas production in the human gut providing the foundation for the , which detects undigested fermentation by measuring exhaled levels after ingestion. The 1970s marked a shift toward genetic and clinical distinctions in lactose intolerance. T. Sahi's 1973 family study established the recessive inheritance pattern of adult-type lactose malabsorption, analyzing relatives of affected individuals to confirm an autosomal recessive genetic basis. This period also saw the formal distinction between primary lactose intolerance—genetically driven and developmental—and secondary forms caused by intestinal injury or disease, as articulated in studies like those by Bayless and Rosensweig in , which highlighted racial differences in lactase deficiency prevalence. A key milestone was the introduction of the first commercial preparations in the early 1970s, derived from yeasts like Kluyveromyces marxianus, enabling exogenous supplementation to aid in dairy products. Advancements in the and focused on , culminating in the mapping of the lactase gene (LCT) on chromosome 2. In 2002, Niina S. Enattah and colleagues identified a (C/T-13910) upstream of LCT as the primary associated with in European populations, explaining why some adults maintain high lactase levels into adulthood. This discovery highlighted as a recent evolutionary adaptation linked to . By the , international health organizations recognized the implications, with the National Institutes of Health's 2010 consensus conference emphasizing lactose intolerance's role in dietary patterns, nutritional deficiencies, and disparities, though its direct impact on and remained understudied. From the 2010s to 2025, research expanded to and microbial influences. Studies revealed multiple independent alleles across global populations, such as the G/C-14010 variant in East Africans and C/G-13907 in the , underscoring regional evolutionary pressures from . investigations gained traction, with a 2019 review citing earlier meta-analyses (including 2018 data) showing that gut like species modulate lactose fermentation and symptom severity in intolerant individuals, potentially alleviating and through prebiotic effects. Recent studies as of 2024 have explored interventions with to improve digestion, with clinical trials demonstrating reduced symptoms via adaptation. This era also saw the proliferation of over-the-counter supplements, with market growth from $1.9 billion in 2025 projections reflecting increased accessibility and consumer demand for symptom management without dietary restriction.

In Non-Human Animals

Occurrence in Animals

In most mammals, activity declines sharply after , leading to lactose intolerance in adulthood as the levels drop to less than 10% of neonatal values. This post-weaning reduction is a universal physiological adaptation observed across nonhuman mammalian species, with nearly 100% exhibiting diminished production once reliant on solid foods. Exceptions to this pattern are rare and primarily linked to in certain domesticated animals, though persistence remains uncommon compared to the norm. Recent genetic studies have identified adaptations in , particularly in populations where up to 91.7% carry relevant alleles, likely due to co-evolution with humans consuming . Among domestic animals, and cats frequently display lactose intolerance, with many adults producing insufficient to digest milk-derived , resulting in gastrointestinal symptoms such as , , , and abdominal discomfort after consumption. A significant proportion of pet exhibit these signs following a lactose load, with studies showing intolerance in approximately 30-50% of tested adults. In contrast, adult horses generally lack substantial activity and are considered intolerant to , though their fermentation processes can partially mitigate undigested sugars, allowing limited tolerance without severe distress. In farm animals like , neonatal calves depend on high maternal levels to digest in during early development, but adults maintain some production in the , particularly in the , enabling potential digestion if were consumed. However, adult cows and similar ruminants rarely encounter in their natural herbivorous diets, avoiding intolerance manifestations. Symptoms of lactose intolerance in affected domestic species mirror those in humans, primarily involving osmotic and gastrointestinal upset due to undigested drawing water into the intestines and promoting bacterial . Veterinary management for lactose-intolerant pets often includes lactose-free milk replacers and formulas that mimic the nutritional profile of maternal without the , preventing digestive issues in , , and orphaned neonates. In wildlife, lactose intolerance is rarely observed or problematic, as most mammals follow non-dairy diets post-weaning and do not consume sources containing .

Comparative Physiology

In most mammals, lactase-phlorizin hydrolase (LPH) activity is elevated in the during the neonatal period to facilitate the digestion of , the predominant in , but declines sharply post-weaning, rendering adults largely lactose intolerant. This pattern aligns with the typical duration of across , where post-weaning consumption is minimal in natural diets. Exceptions occur in marine mammals such as pinnipeds (, sea lions, and walruses), whose is exceptionally high in (up to 50%) and contains only trace amounts of or none at all, reducing the selective pressure for sustained expression beyond infancy. Evolutionary divergences in lactase regulation are evident when comparing mammals to non-human , where lactase activity similarly diminishes after , resulting in adult intolerance to ; for instance, chimpanzees and rhesus monkeys exhibit gastrointestinal distress upon lactose due to low residual enzyme levels. In wild populations, this post-weaning decline is the norm, reflecting adaptations to diets lacking dairy sources, whereas persistence of lactase into adulthood in certain domesticated species or groups correlates with historical reliance on from herd animals. Species-specific variations in lactose handling further highlight physiological diversity. In ruminants like cows, neonatal calves bypass the via the esophageal groove, allowing direct intestinal digestion of milk , but in adults, ferment any undigested carbohydrates, including , producing volatile fatty acids such as butyrate for . animals, such as pigs, mirror the human pattern with high neonatal that wanes post-weaning, though tolerance varies by breed and diet, enabling some post-weaning utilization without severe symptoms. Animal models have provided key insights into lactase regulation. Mice, for example, serve as valuable models for studies, with post-weaning lactase decline mimicking typical mammalian patterns, and engineered strains replicating congenital alactasia to investigate deficiencies and potential therapies. These models have elucidated regulatory mechanisms, such as transcriptional control of the , aiding broader understanding of evolutionary adaptations. Such informs veterinary practices for managing digestive disorders in and illuminates the of across mammals.

References

  1. [1]
    Definition & Facts for Lactose Intolerance - NIDDK
    Lactose intolerance is a condition in which you have digestive symptoms—such as bloating, diarrhea, and gas—after you consume foods or drinks that contain ...
  2. [2]
    Lactose intolerance - Symptoms & causes - Mayo Clinic
    People with lactose intolerance often have diarrhea, gas and bloating after eating or drinking foods containing lactose. The condition is usually harmless, but ...Overview · When to see a doctor
  3. [3]
    Symptoms & Causes of Lactose Intolerance - NIDDK
    Lactose intolerance is caused by problems digesting lactose, the natural sugar in milk. In contrast, milk allergies are caused by your immune system's response ...
  4. [4]
    Treatment for Lactose Intolerance - NIDDK
    In most cases, you can manage the symptoms of lactose intolerance by changing your diet to limit or avoid foods and drinks that contain lactose.<|control11|><|separator|>
  5. [5]
    Lactose Intolerance - StatPearls - NCBI Bookshelf
    Aug 6, 2025 · Lactose intolerance is a clinical syndrome characterized by gastrointestinal symptoms, such as bloating, abdominal pain, flatulence, nausea, ...Etiology · Epidemiology · Evaluation · Treatment / Management
  6. [6]
    Lactose Maldigestion, Malabsorption, and Intolerance
    Nov 1, 2018 · The term hypolactasia refers to the deficiency of the lactase enzyme; this leads to lactose malabsorption, which is defined as an inefficient ...3. Genetic And Biochemical... · 7. Diagnosis · Probiotics As A Future...
  7. [7]
    Milk allergy - Symptoms & causes - Mayo Clinic
    A true milk allergy differs from milk protein intolerance and lactose intolerance. Unlike milk allergy, intolerance doesn't involve the immune system. Milk ...
  8. [8]
    Lactose intolerance and gastrointestinal cow's milk allergy in infants ...
    Dec 12, 2017 · Lactose intolerance (LI) is a common gastrointestinal condition which is due to the inability to digest and absorb dietary lactose. Lactose ...<|separator|>
  9. [9]
    Country, regional, and global estimates for lactose malabsorption in ...
    Jul 7, 2017 · The global prevalence estimate of lactose malabsorption was 68% (95% CI 64-72), ranging from 28% (19-37) in western, southern, and northern Europe to 70% (57- ...
  10. [10]
    Small Intestinal Brush Border Enzymes
    Jan 23, 2025 · Lactase, as its name implies is a disaccharidase that hydrolyses lactose into galactose and glucose; formally, it is a β-glycosidase. Lactose is ...Missing: reaction | Show results with:reaction
  11. [11]
    Glucose transporters in the small intestine in health and disease
    Absorption of monosaccharides is mainly mediated by Na+-d-glucose cotransporter SGLT1 and the facititative transporters GLUT2 and GLUT5. SGLT1 and GLUT2 are ...
  12. [12]
    Lactose digestion in humans: intestinal lactase appears to be ... - NIH
    Jun 8, 2019 · Globally, ∼70% of adults are deficient in intestinal lactase, the enzyme required for the digestion of lactose. In these individuals, the ...
  13. [13]
    Evolution of lactase persistence: an example of human niche ...
    After the weaning period is over, lactase production usually declines, although the mechanisms and evolutionary reasons for this downregulation are not fully ...
  14. [14]
    Overview: Lactose intolerance - InformedHealth.org - NCBI Bookshelf
    Nov 20, 2024 · People who are lactose-intolerant only tolerate small amounts of lactose. · Eating too many dairy products causes digestive problems. · It is ...Bookshelf · Symptoms · CausesMissing: definition | Show results with:definition
  15. [15]
    Lactose intolerance: diagnosis, genetic, and clinical factors - PMC
    Approximately 75% of the world's population loses this ability at some point, while others can digest lactose into adulthood. This review discusses the lactase- ...
  16. [16]
    High Prevalence of Small Intestinal Bacterial Overgrowth in Lactose ...
    Lactose intolerance is a common condition in patients with IBS in northwest Italy (59%), very frequently associated with SIBO (72%).
  17. [17]
    Celiac Disease and Lactose Intolerance | BeyondCeliac.org
    Lactose intolerance is often a symptom of celiac disease. It usually resolves itself after following a strict gluten-free diet.
  18. [18]
    Milk Allergy Vs. Lactose Intolerance - FoodAllergy.org
    Milk allergy should not be confused with lactose intolerance. A food allergy happens when your immune system overreacts to a specific food protein.
  19. [19]
    The role of small intestinal bacterial overgrowth and false positive ...
    May 8, 2020 · Small intestinal bacterial overgrowth (SIBO) leads to carbohydrate malabsorption and therefore to false results during lactose breath and tolerance tests.
  20. [20]
    Fructose and lactose intolerance and malabsorption testing
    Fructose and lactose intolerances are common in FGID and associated with increased non-GI symptoms, but not with specific FGID subtypes.
  21. [21]
    The Perception of Lactose-Related Symptoms of Patients with ... - NIH
    Aug 17, 2022 · Symptoms depending on functional gastrointestinal disorders or reflux disease were frequent in self-reported lactose-intolerant patients.
  22. [22]
    Several different lactase persistence associated alleles and high ...
    Sep 28, 2012 · The -13910 C>T polymorphism, located 14 Kb upstream of the lactase gene (LCT) in the MCM6 gene was associated with lactase persistence (LP) in ...
  23. [23]
    Diversity of Lactase Persistence Alleles in Ethiopia - NIH
    This genetic trait of adult lactase persistence (LP [MIM 223100]) is a recent human adaptation permitting those who carry it to use animal milk more readily as ...Missing: global | Show results with:global
  24. [24]
    Full article: Molecular genetics of human lactase deficiencies
    Dec 21, 2009 · Both lactase deficiencies are autosomal recessive traits and ... Correlation of lactase activities in lactase persistence/non-persistence ...Identification Of The... · Phenotype-Genotype... · Evolutionary Aspects
  25. [25]
    Convergent adaptation of human lactase persistence in Africa and ...
    Based on the breakdown of LD on chromosomes with the T-13910 allele, it is estimated that this allele arose within the past ~2,000-20,000 years within Europeans ...
  26. [26]
    Lactase non-persistence is directed by DNA variation-dependent ...
    Nov 9, 2016 · Since LCT–MCM6 haplotypes exhibit a strong association with lactase non-persistence and persistence in adult Europeans, we hypothesized that ...
  27. [27]
    Differences in DNA Methylation and Functional Expression ... - Nature
    Apr 4, 2018 · Lactase non-persistence, also known as adult-type hypolactasia, is the molecular basis of the inability to hydrolyze the lactose found in milk.
  28. [28]
    Population history and genetic adaptation of the Fulani nomads
    Dec 2, 2019 · We furthermore directly link the T-13910 haplotype with the Lactase Persistence phenotype through a Genome Wide Association study (GWAS) and identify another ...
  29. [29]
    The Genetic Variation of Lactase Persistence Alleles in Sudan and ...
    May 15, 2021 · Our study investigates all currently known lactase persistence-associated variants in 18 populations from Sudan and South Sudan.
  30. [30]
    The evolutionary genetics of lactase persistence in seven ethnic ...
    Feb 11, 2019 · Genetic origins of lactase persistence and the spread of pastoralism in Africa. ... Lactase persistence variants in Arabia and in the African Arabs. Hum ...<|control11|><|separator|>
  31. [31]
    In Vitro Functional Analyses of Infrequent Nucleotide Variants ... - NIH
    This trait, known as lactase persistence (LP, MIM 223100), is carried by some 35% of the world's population and is notably more frequent in populations with a ...Missing: global | Show results with:global
  32. [32]
    Why and when was lactase persistence selected for? Insights from ...
    Jun 8, 2020 · This Unsolved Mystery article explores where and when lactase persistence emerged. The mutation rapidly spread throughout Eurasia between 4000 and 3000 BP.
  33. [33]
    Role of the gut microbiome in mediating lactose intolerance symptoms
    Colonic fermentation may play a role in lactose intolerance in humans 1, 2006. ... A diet low in FODMAPs reduces symptoms in patients with irritable bowel ...
  34. [34]
    Update on lactose malabsorption and intolerance - Gut
    Within this population, individuals with anxiety disorders or GI disease that increase visceral sensitivity are more susceptible to the lactose challenge.
  35. [35]
    Are “Free From” Foods Risk-Free? Lactose-Free Milk Fermentation ...
    Lactose that is not digested arrives in the colon where it is broken down into monosaccharides by gut microbiota and fermented to produce gases and short-chain ...
  36. [36]
    Gut microbiome and serum metabolome alterations associated with ...
    Sep 25, 2024 · Lactose intolerance (LI) is a prevalent condition characterized by gastrointestinal symptoms that arise following lactose consumption.
  37. [37]
    A Narrative Review of Human Clinical Trials to Improve Lactose ...
    Aug 12, 2023 · Further, the β-galactosidase activity of Bifidobacterium enables these individuals to digest lactose more efficiently [4]. Given the selective ...
  38. [38]
    Therapeutic efficacy of fecal microbiota transplantation in severe ...
    May 18, 2025 · This report presents the first documented application of fecal microbiota transplantation (FMT) for the management of extensive multi-food intolerance.Abstract · Introduction · Case report · Discussion
  39. [39]
    Influence of diet on the gut microbiome and implications for human ...
    Apr 8, 2017 · Diet plays a significant role in shaping the microbiome, with experiments showing that dietary alterations can induce large, temporary microbial shifts within ...
  40. [40]
    Hydrogen Breath Tests in Gastrointestinal Diseases - PMC - NIH
    Hydrogen breath tests are specific and sensitive diagnostic tests that can be used to either confirm or eliminate the possibility of carbohydrate malabsorption ...Missing: reliable | Show results with:reliable
  41. [41]
    The importance of methane breath testing: a review - PubMed
    As an example, the hydrogen-based lactose malabsorption test is considered to result in about 5-15% false negatives mainly due to methane production.
  42. [42]
    Lactose tolerance tests: MedlinePlus Medical Encyclopedia
    Aug 12, 2024 · A rise of 20 to 30 mg/dL (1.1 to 1.6 mmol/L) is inconclusive. Note: Normal value ranges may vary slightly among different laboratories.
  43. [43]
    The importance of stool tests in diagnosis and follow-up of ... - NIH
    A fecal pH below 5.5 indicates acidic feces. In babies fed with breastmilk, the fecal pH is mildly acidic. The fecal osmolarity is equal to serum osmolarity ( ...
  44. [44]
    13910C>T and 22018G>A LCT gene polymorphisms in diagnosing ...
    Genetic testing including the 13910C>T and 22018G>A LCT polymorphisms is useful in diagnosing lactose intolerance, but only for children older than 6 years.
  45. [45]
    Genetic Testing for Lactase Insufficiency AHS – M2080 | Providers
    The gold standard is the measurement of lactase, sucrase, and maltase activity through intestinal biopsies. However, this method is not commonly used due to its ...
  46. [46]
    Lactase Deficiency Diagnosed by Endoscopic Biopsy-based Method ...
    Jan 30, 2023 · For the objective diagnosis of LD, a useful rapid test kit (Lactose Intolerance Quick Test [LQT]) to assess lactase activity in the intestine ...
  47. [47]
    [PDF] Faecal Sugar Chromatography
    Identification of individual sugars in faecal material can provide diagnostic clues. This test does not have a role in investigating adult lactose intolerance.
  48. [48]
    Lactose intolerance in infants
    Dec 14, 2010 · Chromatography was positive in 39 and trace positive in a further 36, suggesting that chromatography is more specific for lactose intolerance.
  49. [49]
    Small Bowel Juice Disaccharidase Activity in the Pre-Term Infant .68
    Sep 1, 1997 · Disaccharidase activity was determined colorimetrically .RESULTS: 71/92 (77%) of lactase, 52/94 (55%) of sucrase and 59/93(63%) of maltase ...
  50. [50]
    Eating, Diet, & Nutrition for Lactose Intolerance - NIDDK
    Talk with your doctor or a dietitian about changing your diet to manage lactose intolerance symptoms while making sure you get enough nutrients.
  51. [51]
  52. [52]
    [PDF] Rethinking Lactose Intolerance: A Guide for Including Dairy Foods in ...
    Lactose Content in Dairy Foods​​ You won't find this on the food label, but a cup of milk contains about 12 grams of lactose. Maldigesters should stay below 12 ...<|control11|><|separator|>
  53. [53]
    Nutritional management of lactose intolerance - PubMed Central - NIH
    Jun 26, 2020 · Lactose intolerance (LI) occurs when the small intestine does ... headache, severe fatigue, cognitive dysfunction, muscle and/or joint ...Lactose-Free Alternatives · Yogurt And Other Fermented... · Non-Dairy Substitutes<|control11|><|separator|>
  54. [54]
    Learn More – What can lactose-intolerant people eat? - NCBI
    Nov 20, 2024 · People who are lactose intolerant are still able to eat and drink certain amounts of dairy products – preferably together with other foods.Bookshelf · How Much Lactose Can... · Can Lactase Products Or...<|control11|><|separator|>
  55. [55]
    LACTASE: Uses, Side Effects, and More - WebMD
    Effective for​​ Taking lactase by mouth before consuming milk or milk products helps digest lactose, a milk sugar. This prevents symptoms such as diarrhea, ...
  56. [56]
    Lactase Capsules & Tablets: Uses & Side Effects - Cleveland Clinic
    The lactase supplement prevents bloating, diarrhea and gas caused by lactose intolerance. It comes in a capsule or tablet form.
  57. [57]
    Lactaid, Colief (lactase enzyme) dosing, indications, interactions ...
    Lactose Intolerance. Take 3,000-9,000 units PO with meals or dairy. Dosing considerations. If still eating or drinking dairy products after 30-45 min, may need ...
  58. [58]
    Lactase Dosage Guide + Max Dose, Adjustments - Drugs.com
    Oct 20, 2025 · Usual Adult Dose for Lactose Intolerance: Original Strength: Swallow three caplets with first bite of dairy foods to help prevent symptoms.
  59. [59]
    Possible therapeutic use of loperamide for symptoms of lactose ...
    Lo may be studied further as an adjunctive treatment of lactose intolerance in an effort to reduce the need for complete lactose digestion.
  60. [60]
    6 Ways To Relieve Lactose Intolerance Symptoms
    Feb 19, 2025 · ... symptoms, such as gas, bloating and stomachaches. Antidiarrheal medications may have loperamide (Imodium®, Maalox Anti-Diarrheal®) or ...
  61. [61]
    Calcium - Health Professional Fact Sheet
    Jul 11, 2025 · Options for increasing calcium intakes in individuals with lactose intolerance include consuming lactose-free or reduced-lactose dairy products ...
  62. [62]
    Effect of lactase on symptoms and hydrogen breath levels in lactose ...
    Dec 1, 2020 · It is suggested that only about 35% of people worldwide are lactase ... The evolution of lactase persistence in Europe. A synthesis of ...Missing: global | Show results with:global
  63. [63]
    Novel formulation of neutral lactase improves digestion of dairy ...
    An observational study with 64 persons showed high acceptance of the product and a highly significant reduction of symptoms: abdominal pain: 58%; bloating: 75%; ...Missing: effectiveness | Show results with:effectiveness
  64. [64]
    Effects of probiotics administration on lactose intolerance in adulthood
    The results showed that probiotic administration alleviated the symptoms of lactose intolerance, including abdominal pain, diarrhea, and flatulence.
  65. [65]
    Impact of short-chain galactooligosaccharides on the gut ... - PNAS
    Jan 3, 2017 · Consumption of dairy foods by lactose-intolerant individuals may result in clinical symptoms including abdominal pain, diarrhea, bloating, ...
  66. [66]
    Peroral gene therapy of lactose intolerance using an adeno ... - Nature
    Lactose intolerance is most commonly associated with a reduction in intestinal lactase activity. Lactose digestion is dependent on the enzyme lactase-phlorizin ...Missing: personalized | Show results with:personalized
  67. [67]
    An engineered genetic circuit for lactose intolerance alleviation
    Jul 5, 2021 · Here, we synthesized a tri-stable-switch circuit equipped with high β-galactosidase activity and pH rescue ability.
  68. [68]
    [PDF] Understanding the Genetic and Evolutionary Basis of Lactase ...
    Sep 2, 2024 · For instance, CRISPR/Cas9 has been used to edit the LCT gene in mice, resulting in the production of lactase enzymes and improved lactose ...
  69. [69]
    The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota ...
    Apr 8, 2025 · The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals. ClinicalTrials.gov ID NCT06915129.
  70. [70]
    Development of Personalized Nutrition: Applications in Lactose ...
    The diagnosis and management of lactose intolerance (LI), a common condition with a strong inter-individual component, is explored as an interesting example.
  71. [71]
    Lactose intolerance - Genetics - MedlinePlus
    Mar 24, 2023 · Lactase nonpersistence is most prevalent in people of East Asian descent, with 70 to 100 percent of people affected in these communities.
  72. [72]
    Genetics of Lactose Intolerance: An Updated Review and Online ...
    Sep 3, 2020 · Congenital lactase deficiency is extremely rare and appears at the onset of nursing, caused by severe mutations on both alleles of the LCT gene ...
  73. [73]
    [PDF] Lactose Intolerance: Topic of the Month
    Nov 20, 2022 · Antibiotics may cause temporary lactose intolerance or diarrhea due to the change in the bacterial flora of the gut. These symptoms are usually ...
  74. [74]
    Lactose Intolerance: Symptoms, Causes, Diagnosis, Stages ...
    Radiation therapy: Radiation therapy to the abdomen can damage the small intestine and decrease the production of lactase enzyme, leading to lactose intolerance ...Missing: antibiotics | Show results with:antibiotics
  75. [75]
    Lactose Intolerance – Cause, Symptoms, Diagnosis, Treatment
    Feb 22, 2024 · Age. You produce less lactase as you grow older. ; Ethnicity. If your heritage is African, Asian, Hispanic, or Native American, your risk is ...
  76. [76]
    Study on influence of age, gender and genetic variants on lactose ...
    Aug 6, 2025 · Subject study suggests that gender and genotype may be associated with development of LI. Association of age with LI was marginal.
  77. [77]
    Health implication of lactose intolerance and updates on its dietary ...
    The global prevalence of lactose malabsorption estimated was 68% and this further confirmed the high prevalence of lactose malabsorption worldwide. Scientific ...
  78. [78]
    Increasing Cases of Lactose Intolerance Drives Demand for
    Jul 22, 2024 · As a result, the demand for dairy alternatives has increased in both developed and developing countries. The diversification of vegan food ...<|separator|>
  79. [79]
    Bone Mineral Density and the Risk of Type-2 Diabetes in ...
    Sep 5, 2024 · ... lactose intolerance, significantly increased the risk of developing type-2 diabetes. ... type-2 diabetes, osteoporosis, or a high risk of ...
  80. [80]
    Lactose Intolerance and Bone Health: The Challenge of Ensuring ...
    Mar 28, 2019 · Lactose intolerance may lead to reduced bone density and fragility fractures when accompanied by decreased intake or avoidance of dairy.
  81. [81]
  82. [82]
    The Two Faces of Cow's Milk and Allergy - NIH
    Aug 19, 2019 · Cow's Milk Allergy. The first recorded food allergy to dairy was described by Hippocrates (460–375 BC) that mentioned how some people could eat ...
  83. [83]
    Lactose Intolerance: What Your Breath Can Tell You - MDPI
    Lactose intolerance has seen recognized as a clinical syndrome characterized by pain, abdominal distention, flatulence, and diarrhea after the consumption ...
  84. [84]
    [PDF] Historical Aspects of Milk Consumption in South, Southeast, and ...
    Jun 10, 2017 · Lactose intolerance (LI) is ascribed as one of the reasons for low milk consumption in. Asia. It is generally viewed that LI is primarily due to ...
  85. [85]
    Lactose intolerance seems linked to ancestral struggles with harsh ...
    Jun 1, 2005 · Lactose intolerance seems linked to ancestral struggles with harsh climate and cattle diseases, Cornell study finds · By Susan S. Lang · Links.
  86. [86]
    Milk through the millennia - ASBMB
    Oct 8, 2020 · But for nearly two-thirds of adults worldwide who are lactose intolerant, milk, cheeses and other dairy products cause a different kind of pain.
  87. [87]
    Unpalatable Truths: Food and Drink as Medicine in Colonial British ...
    Mar 13, 2018 · The association between food and the maintenance of health was a concern of Anglo-Indian doctors, dieticians and the British authorities ...
  88. [88]
    The Interrelationships between Lactose Intolerance and the Modern ...
    Over the centuries, three factors allowed humans to overcome limitations imposed by lactose intolerance: (i) mutations, which occurred in particular ...Missing: weakness | Show results with:weakness<|separator|>
  89. [89]
    Dairying and the evolution and consequences of lactase persistence ...
    Jun 14, 2023 · The domestication of milk-producing mammals and the use of milk products has been widespread among human populations throughout the past 10,000 ...Missing: 2000-20000 | Show results with:2000-20000
  90. [90]
    Production and excretion of hydrogen gas in man - PubMed
    Production and excretion of hydrogen gas in man. N Engl J Med. 1969 Jul 17;281(3):122-7. doi: 10.1056/NEJM196907172810303. Author. M D Levitt. PMID: 5790483 ...Missing: breath test intolerance
  91. [91]
    RECESSIVE INHERITANCE OF ADULT-TYPE LACTOSE ...
    Oct 13, 1973 · To study the genetic control of adult lactose malabsorption (L.M.) 252 relatives of 11 probands over 20 years old and 101 spouses of these ...
  92. [92]
    Genetics of Primary Adult Lactase Deficiency - Gastroenterology
    One hundred-five subjects (63%) with a maximal glucose rise of less than 20 mg per 100 ml during the lactose tolerance tests were considered to have primary ...
  93. [93]
    Lactase - an overview | ScienceDirect Topics
    Lactases have been commercially available for lactose hydrolysis from the 1970's. Commercial sources include enzymes from yeasts, fungi and bacteria.
  94. [94]
    Identification of a variant associated with adult-type hypolactasia
    Sequence analyses of the coding and promoter regions of LCT, the gene encoding LPH, has revealed no DNA variations correlating with lactase non-persistence.
  95. [95]
    National Institutes of Health Consensus Development Conference
    Jun 15, 2010 · Even in persons with lactose intolerance, small amounts of milk, yogurt, hard cheeses, and reduced-lactose foods may be effective management ...
  96. [96]
    A worldwide correlation of lactase persistence phenotype and ...
    Feb 9, 2010 · We present a global summary of the extent to which current genetic knowledge can explain lactase persistence phenotype frequency.
  97. [97]
    Lactase Enzyme Market Size and Share Forecast Outlook 2025 to ...
    The global lactase enzyme market is projected to increase from USD 1.9 billion in 2025 to USD 3.9 billion by 2035, with a CAGR of 7.5% during the forecast ...
  98. [98]
    Can changing the microbiome reverse lactose intolerance?
    Apr 11, 2019 · Recent studies have shown that the symptoms of lactose intolerance can be relieved in some people by changing the population of their intestinal microbes.
  99. [99]
    Food Intolerance in Dogs | VCA Animal Hospitals
    One fairly common carbohydrate reaction in dogs is lactose intolerance. The signs include diarrhea, bloating, and abdominal discomfort after ingesting cow's or ...
  100. [100]
    Effects of dietary supplementation with increasing doses of lactose ...
    In conclusion, 8 of 14 dogs displayed a good tolerance (absence of gastrointestinal signs) up to the highest dose of lactose (2 g/kg BW0.75/d). An evident ...
  101. [101]
    Carbohydrate digestion and absorption in the equine small intestine
    monosaccharide tolerance tests. Horses older than three years of age are unable to hydrolyse lactose, but young and adult horses are fully capable of rapidly ...
  102. [102]
    Lactase Activity in Steers Fed Large Amounts of Dried Whole Whey
    Lactase activity of intestinal contents was similar for both treatments; it was greatest in the duodenum and lowest in the ileum and large intestine.Missing: adult | Show results with:adult
  103. [103]
    Adverse food reactions (Proceedings) - DVM360
    Many adult dogs and cats have little lactase activity in the brush border and develop bloating, flatulence, abdominal discomfort, and diarrhea after ingestion ...
  104. [104]
    [PDF] Lactose intolerance in dogs: Review
    May 16, 2025 · 4.1.​​ Lactose intolerance could strike many adult dogs and is likely to cause symptoms such as diarrhea, bloating, and abdominal pain [38, 40].
  105. [105]
    A Wilder View: A look at why animals are lactose intolerant - KPAX
    May 17, 2023 · But most mammals become lactose intolerant after weaning. That means they lose the ability to digest lactose as they grow older because their ...
  106. [106]
    Comparative Digestive Physiology - H. Karasov - Wiley Online Library
    Apr 1, 2013 · In most mammals lactase activity is high at birth and declines sharply around weaning. Ingestion of large amounts of lactose post-weaning ...
  107. [107]
    Evolution of Pinnipedia lactation strategies: a potential role for α ...
    Within the Pinnipedia (seals, sea lions and walruses), lactose has been detected at trace concentrations in the milk of true seals (Phocidae; Pilson 1965; ...
  108. [108]
    Gene–culture coevolution: lactase persistence - Oxford Academic
    Pinnipeds—Pacific seals, sea lions, and walruses—are said to be the only mammals whose milk does not contain lactose (Kretchmer 1972). The α-lactalbumin ...<|separator|>
  109. [109]
    Milk Lactose From A to Zebra
    Species that fast during lactation, including bears and whales, produce milks with very little lactose, whereas species that lactate for prolonged periods of ...
  110. [110]
    Lactose malabsorption in two sibling rhesus monkeys (Macaca ...
    Two rhesus monkeys showed lactose intolerance, experiencing severe diarrhea and weight loss on a lactose formula, which resolved with a lactose-free diet.
  111. [111]
    The Evolution of Lactose Tolerance — HHMI BioInteractive Video
    Aug 26, 2014 · All adult mammals but humans are lactose intolerant. Follow human geneticist Spencer Wells, director of the Genographic Project of the ...
  112. [112]
    The ruminant digestive system - University of Minnesota Extension
    In calves, the esophageal grooves allows milk to bypass the rumen and directly enter the abomasum. Rumen development occurs following a change in diet and ...
  113. [113]
    Feeding Lactose to Increase Ruminal Butyrate and the Metabolic ...
    Feeding lactose from 21 d pre- to 21 d postcalving increased the proportions of butyrate in rumens and BHBA in blood of dairy cows. This increase in circulating ...
  114. [114]
    The role of lactose in weanling pig nutrition - NIH
    Jan 11, 2021 · Lactose is a digestible energy source that aids transition to solid feed, improves growth, and may act as a prebiotic, but its digestibility ...
  115. [115]
    Formula-feeding reduces lactose digestive capacity in neonatal pigs
    We investigated if feeding milk replacer (infant formula) as an alternative to colostrum has compromising effects on nutrient digestive function in the ...